Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01582685

Exercise in Breast Cancer Survivors

Exercise in Breast Cancer Survivors: Analysis of Angiogenic Profile

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Mississippi Medical Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesize that exercise in postmenopausal breast cancer survivors will result in an increase in the plasma concentrations of angiostatic factors and a decrease in the plasma concentrations of angiogenic factors. Exercise is expected to result in a circulating angiostatic phenotype that inhibits adipose tissue mass, growth of breast cancer tumor, growth of microscopic residual disease after breast cancer resection, decreases rates of local-regional recurrence, decreases rates of distant recurrence, and increases survival.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExerciseThe participant will exercise for 16 weeks under supervision. The exercise regimen is increased slowly over 16 weeks.

Timeline

Start date
2012-04-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2012-04-23
Last updated
2014-12-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01582685. Inclusion in this directory is not an endorsement.

Exercise in Breast Cancer Survivors (NCT01582685) · Clinical Trials Directory